Type of Posting: Notice of Intent to Revise
Posting Date: 28–Aug–2020
Targeted Official Date: 01–May–2021, Interim Revision Announcement
Expert Committee: Small Molecules 4
In accordance with the Rules and Procedures of the Council of Experts, this is to provide notice that the Small Molecules 4 Expert Committee intends to revise the Ioversol Injection monograph.
Comments were received that USP Ioversol Related Compound A RS is chemically the same as USP Iohexol Related Compound B RS. It is proposed to discontinue carrying the USP Ioversol Related Compound A RS in USP Reference Standards inventory, and to replace all references to USP Ioversol Related Compound A RS with references to USP Iohexol Related Compound B RS.
It is anticipated that the proposed revision will be published in the future as an Interim Revision Announcement (IRA) in Pharmacopeial Forum (PF) 46(6) pursuant to the Rules and Procedures.
Should you have any questions, please contact Ravi Ravichandran, Principal Scientific Liaison (301–816-8330 or email@example.com).